Infant Bacterial Therapeutics AB (publ) (STO:IBT.B)
Sweden · Delayed Price · Currency is SEK 48.45
-1.85 (-3.68%)
At close: Mar 2, 2026
STO:IBT.B Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
8
Market Cap
677.61M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | 4.00K | -73.00K | -94.81% |
| Dec 31, 2023 | 77.00K | 65.00K | 541.67% |
| Dec 31, 2022 | 12.00K | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Cantargia AB | 316.70M |
| Genovis AB (publ.) | 129.65M |
| Oncopeptides AB | 71.12M |
| Elicera Therapeutics AB | 10.86M |
| Corline Biomedical AB | 8.59M |
| Medivir AB | 8.50M |
| Xspray Pharma AB | 6.43M |
| Lipum AB | 1.93M |